CONCLUSIONI

La procalcitonina sembra essere un marcatore sensibile e specifico per la SIRS settica nei vitelli. Potranno essere effettuati ulteriori studi per indagare il ruolo della PCT e per accorciare la terapia antibiotica, come è già stato proposto in medicina umana. Inoltre prendere in considerazione il tempo di recupero dalla SIRS settica, e non solo il risultato di recupero, potrebbe essere un obiettivo per ulteriori studi sui livelli di PCT e per l’analisi della sopravvivenza.

BIBLIOGRAFIA

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-10.

2. Al-Nawas B, Shah PM. Procalcitonin in patients with and without immunosuppression and sepsis. Infection. 1996; 24(6): 434-6.

3. Ardaillou R, Sizonenko P, Meyrier A, Vallée G, Beaugas C. Metabolic clearance rate of radioiodinated human calcitonin in man. J Clin Invest. 1970; 49: 2345-52.

4. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentration in patients with sepsis and infection. Lancet. 1993; 341: 515-18.

5. Basoglu, A, Sen I, Sevinc M, Simsek A. Serum Concentrations of Tumor Necrosis Factor‐a in Neonatal Calves with Presumed Septicemia. J Vet Int Med. 2004; 18(2): 238-41.

6. Basoglu A, Baspinar N, Tenori L, Hu X, & Yildiz R. NMR based metabolomics evaluation in neonatal calves with acute diarrhea and suspected sepsis: A new approach for biomarkers. Metabolomics. 2014; 4(134), 2153-769.

7. Bieniek K, Szuster-Ciesielska A, Kamińska T, Kondracki M, Witek M, & Kandefer- Szerszeń M. Tumor necrosis factor and interferon activity in the circulation of calves after repeated injection of low doses of lipopolysaccharide. Vet Immunol Immunop. 1998; 62(4), 297-307.

8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992; 101(6), 1644-55.

9. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997; 112: 235-43.

10. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996; 24(7): 1125-8.

11. Bonelli F, Meucci V, Divers T, Radcliffe R, Jose-Cunilleras E, Corazza M, Sgorbini M. Evaluation of plasma Procalcitonin concentrations in healthy foals and foals affected by septic Systemic Inflammatory Response Syndrome. J of Equine Vet Sci. 2015a; 35(8), 645-49.

12. Bonelli F, Meucci V, Divers TJ, Jose‐Cunilleras E, Corazza M, Tognetti R, Sgorbini M. Plasma procalcitonin concentration in healthy horses and horses affected by systemic inflammatory response syndrome. J Vet Intern Med. 2015b; 29(6), 1689-1691.

13. Brain SD, Tippins JR, Morris HR, Maclntyre I, & Williams TJ Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol. 1986; 87(4), 533- 536.

14. Brewer B D, Koterba AM Development of a scoring system for the early diagnosis of equine neonatal sepsis. Equine veterinary journal. 1988; 20(1), 18-22.

15. Brunn GJ, Wijdicks MF, Platt JL. Toward a modern concept of sepsis: new answers to ancient questions. Discov Med. 2006; 6(31): 11-7.

16. Cerón JJ, Eckersall PD, & Martínez‐Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Path. 2005; 34(2), 85-99.

17. Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab. 2008; 295(3): E686- 91.

18. Copp DH, Cameron EC, Cheney BA, Davidson AGF, & Henze KG Evidence for calcitonin—a new hormone from the parathyroid that lowers blood calcium. Endocrinology. 1962; 70(5), 638-649.

19. Daley C, Lim I, Modra J, Wilkinson I. Comparative evaluation of nonradiometric BACTEC and improved oxoid signal blood culture systems in a clinical laboratory. J Clin Microbiol. 1990; 28, 1586-90.

20. Dandona P, Nix D, Wilson M F, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79(5): 1605-08.

343(2): 108–17.

22. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343(1): 37–49.

23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Calandra T (2008). Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intens Care Med, 34(1), 17-60.

24. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997; 112 (6 Suppl): 321S-9S.

25. Domenech VS, Nylen ES, White JC, Snider RH, Becker KL, Landmann R, Muller B. Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection- specific response elements within the calcitonin I gene promoter. J Investig Med. 2001; 49(6): 514-21.

26. Eckersall, PD, & Bell R. (2010). Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. The veterinary journal, 185(1), 23-27.

27. Ercan N, Tuzcu N, Başbug O, Tuzcu M, & Alim A. (2016). Diagnostic value of serum procalcitonin, neopterin, and gamma interferon in neonatal calves with septicemic colibacillosis. Journal of Veterinary Diagnostic Investigation, 28(2), 180-183.

28. Ercan N, Tuzcu N, & Basbug O. (2014). The evaluation of important biomarkers in healthy cattle. inflammation, 3(7), 8.

29. Fecteau G, Smith BP, & George LW (2009). Septicemia and meningitis in the newborn calf. Veterinary Clinics of North America: Food Animal Practice, 25(1), 195-208. 30. Fecteau G, Van Metre DC, Pare J, Smith BP, Higgins, R, Holmberg CA, & Guterbock

W. (1997). Bacteriological culture of blood from critically ill neonatal calves. The Canadian Veterinary Journal, 38(2), 95.

31. Floras, A. N. K., Holowaychuk, M. K., Hodgins, D. C., Marr, H. S., Birkenheuer, A., Sharif, S., ... & Bienzle, D. (2014). Investigation of a Commercial ELISA for the Detection of Canine Procalcitonin. J Vet Intern Med. 28(2), 599-602.

32. Giunti M, Peli A, Battilani M, Zacchini S, Militerno G, Otto CM. Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care. 2010; 20(5): 523-7.

procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med. 2007; 30(2): E75-85. 
76.

34. Hatzistilianou M, Rekliti A, Athanassiadou F, Catriu D. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res. 2010; 59(5): 339-47. 


35. Herget-Rosenthal S, Klein T, Marggraf G, Hirsch T, Jakob HG, Philipp T, Kribben A. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol. 2005; 61(2): 180-6.

36. Horadagoda NU, Knox KM, Gibbs HA, Reid SW, Horadagoda A, Edwards SE, & Eckersall PD. (1999). Acute phase proteins in cattle: discrimination between acute and chronic inflammation. The Veterinary Record, 144(16), 437-441.

37. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2): 138-50.

38. Johnson GB, Brunn GJ, Samstein B, Platt JL. New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery. 2005; 137(4): 393- 5.

39. Kelley MJ, Snider RH, Becker KL, Johnson B E. Small cell lung carcinoma cell line express mRNA for calcitonin and alpha-and beta-calcitonin gene related peptide. Cancer Lett. 1994; 81: 19-25.

40. Kehrli ME, Weigel KA, Freeman AE, Thurston JR, and Kelley DH. 1991. Bovine sire effects on daughters’ in vitro blood neutrophil functions, lymphocyte blastogenesis, serum complement and conglutinin levels. Vet. Immunol. Im- munopathol. 27:303– 319.

41. Koets AP, Adugna G, Janss LLG, Van Weering HJ, Kalis CHJ., Wentink GH, & Schukken YH. (2000). Genetic variation of susceptibility to Mycobacterium avium subsp. paratuberculosis infection in dairy cattle. J Dairy Sci. 83(11), 2702-2708. 42. Kretzschmar M, Kruger A, Schirrmeister W. Procalcitonin following elective partial liver

resection-origin from the liver? Acta Anaesthesiol Scand. 2001; 45(9): 1162-7.

43. Kuzi S, Aroch I, Peleg K, Karnieli O, Klement E, Dank G. Canine procalcitonin messenger RNA expression. J Vet Diagn Invest. 2008; 20(5): 629-33.

44. LeMoullec JM, Jullienne A, Chenais J, Lasmoles F, Guliana J M, Milhaud G Moukhtar M S. The complete sequence of human preprocalcitonin. FEBS Lett. 1984; 167: 93-7.

45. Linscheid P, Seboek D, Nylén ES, Langer I, Schlatter M, Becker KL, Keller U, Muller B. In vitro and in vivo calcitonin-1 gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-84.

46. Lofstedt J, Dohoo IR, & Duizer G. (1999). Model to predict septicemia in diarrheic calves. Journal of Veterinary Internal Medicine, 13(2), 81-88.

47. Lohmann KL, MH Barton. Endotoxemia. In Reed SM, Bayly WM, Sellon DC editors. Equine Internal Medicine: 3ed. Saunders Elsevier, St. Louis, USA; 2010, pp. 807-823. 48. Mackay I, Rosen FS. Innate immunity. N Engl J Med. 2000; 343(5): 338-44.

49. Mallard BA, Dekkers JC, Ireland MJ, Leslie KE, Sharif S, Vankampen CL & Wilkie BN. (1998). Alteration in immune responsiveness during the peripartum period and its ramification on dairy cow and calf health. J Dairy Sci. 81(2), 585-595.

50. Matwiyoff GN, Prahl JD, Miller RJ, Carmicheal JJ, Amundson DE, Seda GD. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res. 2012; 61: 401-9.


51. Meisner M. Procalcitonina. Un nuovo, innovativo parametro di infezione. Caleidoscopio Italiano, 1997, Genova, Italia.

52. Meisner M, Muller V, Khakpour Z, Toegel E, Redl H. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock. 2003; 19(2): 187-90.

53. Mol JA, Kwant MM, Arnold IC, & Hazewinkel HA (1991). Elucidation of the sequence of canine (pro)-calcitonin. A molecular biological and protein chemical approach. Regulatory peptides, 35(3), 189-195.

54. Monneret G, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells. Infection. 1999; 27(1): 34-5.

55. Moya F, Nieto A, Candela LR. Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem. 1975; 55: 407-13.

56. Moore JN, Vandenplas ML. Is the systemic inflammatory response syndrome or endotoxemia in horses with colic? Vet Clin Eq Pract. 2014; 30: 337-51.

57. Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez- Domenech V, Bergmann A, Muller B. Production of procalcitonin (PCT) in non- thyroidal tissue after LPS injection. Horm Metab Res. 2003; 35(5): 290-5.

58. Muller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001; 86: 396–404.

59. Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007; 7: 10.

60. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001; 163(2): 316-21. 61. Nylén ES, Alarifi A. Humoral markers of severity and prognosis in critical illness. Best

Pract Res Clin Endocrinol Metab. 2001; 15: 553-73.

62. Nishikura T. Procalcitonin (PCT) production in a thyroidectomized patient. Intensive Care Med. 1999; 25(9): 1031.

63. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jager L, Reinhart K. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis- related cytokines in vitro. J Lab Clin Med. 1999; 134(1): 49-55.

64. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med. 2000; 28(4 Suppl): N3-12.

65. Ogoshi M, Inoue K, Naruse K, & Takei Y. (2006). Evolutionary history of the calcitonin gene-related peptide family in vertebrates revealed by comparative genomic analyses. Peptides, 27(12), 3154-3164.

66. Petitjean S, Mackensen A, Engelhardt R, Bohuon C, Assicot M. Induction de la procalcitonine circulante apres administration intraveineuse d’endotoxine chez l ‘homme. Act. Parm Biol Clin. 1994; 1: 265-8.

67. Picariello C, Lazzeri C, Valente S, Chiostri M, Attana` P, Gensini GF. Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data. Acute Card Care. 2010; 12(3): 96-101.

68. Preas HL, Nylén ES, Snider R H, Becker K L, White JC, Agosti JM, Suffredini A F. Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis. 2001; 184: 373-6.

69. Pusterla N, Magdesian G, Mapes S, Leutenegger CM. Expression of molecular markers in blood of neonatal foals with sepsis. Am J Vet Res. 2006; 67: 1045-9. 70. Redl H, Schlag G, Tögel E, Assicot M, Bohuon C. Procalcitonin release patterns in a

baboon model of trauma and sepsis: relationship to cytokines and neopterin. Crit Care Med. 2000; 28: 3569-3663.

71. Riedel S (2012). Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagnostic microbiology and infectious disease, 73(3), 221- 227.

72. Rieger M, Kochleus C, Teschner D, Rascher D, Barton AK, Geerlof A, Kremmer E, Schmid M, Hartmann A, Gehlen H. A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses. Anal Bioanal Chem. 2014; 406(22): 5507-12.

73. Robinson, J. A., Allen, G. K., Green, E. M., Garner, H. E., Loch, W. E., & Walsh, D. M. (1993). Serum interleukin-6 concentrations in endotoxin-infused neonatal foals. Am J Vet Res. 54(9), 1411-1414.

74. Rohner P, Pepey B, Auckenthaler R, 1995. Comparison of BacT/Alert with signal blood culture system. J Clinic Microbiol. 33, 313-317.

75. Rosenberger, G. (1990). Die klinische Untersuchung des Rindes.G Rosenberger–3. Aufl., Verlag Paul Parey-Berlin und Hamburg.

76. Roy MF. Sepsis in adults and foals. Vet Clin North AM Equine Pract. (2004); 20 (1): 41-61.

77. Schuman RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide-binding protein, Science 1990; 249 (4975): 1429-31.

78. Silomon M, Bach F, Ecker D, Graeter T, Grundmann U, Larsen R. Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region. Anaesthesist. 1999; 48(6): 395-8.

79. Silipo A, Erbs G, Shinya T, Dow J M, Parrilli M, Lanzetta R, & Molinaro A (2010). Glyco- conjugates as elicitors or suppressors of plant innate immunity. Glycobiology, 20(4), 406-419.

80. Smith BP (2015) Large animal internal medicine, 5th Edn. Elsevier Health Sciences, 2015: pp 294 – 301.

81. Stockham SL, & Scott MA, 2013. Leucocytes, Analytical principles and methods. In: Fundamentals of veterinary clinical pathology. John Wiley & Sons.

82. Soreng K, Levy HR. Procalcitonin: an emerging biomarker of bacterial sepsis. Clinical Microbiology Newsletter. 2011; 33(22): 171-178.

83. Taylor S. A review of equine sepsis. Equine Vet Educ. 2015; 27(2): 99-109.

84. Terra RL, Reynolds JP, 2015. Ruminant History, Physical Examination, Welfare Assessment, and Records. In: Smith B P (Ed.). Large Animal Internal Medicine, 5th Edn. Elsevier Health Sciences, pp. 2-12.

85. Germs TL. N Engl J Med. 1972; 287(11): 553-5. 


86. Tobias PS. Lipopolysaccharide-binding protein. In Brade H, Opal SM,

Vogel SN editors. Endotoxin in Health and Disease. Marcel Dekker, New York, USA; 1999. 


87. Tomlinson JE, Blikslager AT. Interactions between lipopolysac- charide and the intestinal epithelium, J Am Vet Med Assoc. 2004; 224: 1446-52. 


88. Töllner U. (1982). Early diagnosis of septicemia in the newborn. Eur J Pediatr. 138(4), 331-337.

89. Toribio RE, Kohn CW, Leone GW, Capen CC, Rosol T J. Molecular cloning and expression of equine calcitonin, calcitonin gene-related peptide-I, and calcitonin gene- related peptide-II. Mol cell endocrinol. 2003; 199: 119-128.


90. Trefz FM, Feist M, Lorenz I, 2016. Hypoglycaemia in hospitalised neonatal calves: Prevalence, associated conditions and impact on prognosis. The Veterinary Journal 217, 103-108.

91. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs 
and the LPS-activation cluster. Trends Immunol 2002; 23(6): 301-4.

92. Tzung SP, Mahl TC, Lance P, Andersen V, & Cohen SA. (1992). Interferon‐α prevents endotoxin‐induced mortality in mice. Eur J Immunol. 22(12), 3097-3101.

93. Weiss DJ, & Rashid J. (1998). The Sepsis‐Coagulant Axis: A Review. J Vet Intern Med. 12(5), 317-324.

Large Animal Internal Medicine, 5th Edn. Elsevier Saunders, St. Louis, MO, USA, pp. 461-637.

95. Yilmaz Z, Ilcol YO, Ulus IH. Endotoxin increases plasma leptin and gherlin levels in dogs. Crit Care Med. 2008; 36: 828-33.